Evolution of the Average Target: Imerys

Evolution of the Target Price: Imerys

Changes in Analyst Recommendations: Imerys

46c86f85eabaeb2f597.Enx3nh4OADJ3kl7hBv2RT5aTM4psR7dvDoYzGbfBPeg.aCwVwSk5TXok2GuOYbfLf-PXdb8iMY4lOt90LIaHYpFdBUXkeUxTfRbzEw~ea9b2a87b5debcb3caa9b9f518a89f9a
04/08 Imerys: H1 2026: The recovery is thinner than reported EBITDA suggests Alphavalue
30/04 Imerys: Q1: FX and restructuring flush earnings Alphavalue
30/04 Schneider Electric, Capgemini, Societe Generale... stocks to watch today in Paris Zonebourse
02/04 Oddo BHF maintains Outperform rating on Imerys but trims price target Zonebourse
18/03 AlphaValue/Baader Europe Slashes EPS Estimates for Imerys Amid 'More Conservative' View MT
18/03 Imerys: EPS cut (2025: from € 1.87 to -4.01, 2026: from € 2.30 to 1.22) Alphavalue
23/02 Imerys: FY 2025: Imerys turns to cost cutting as recovery remains elusive Alphavalue
23/02 Oddo BHF Maintains Outperform Rating on Imerys Zonebourse
01/11/25 Imerys: Cautious Optimism: Imerys Lays the Groundwork for Recovery Alphavalue
21/08/25 AlphaValue/Baader Europe Cuts EPS Estimates for Imerys on Weaker-than-expected H1 Results MT
20/08/25 Imerys: AlphaValue confirms buy recommendation Zonebourse
20/08/25 Imerys: Target cut by -26.3% Alphavalue
08/08/25 Imerys: H1 2025: Imerys struggles amid broad slowdown Alphavalue
30/07/25 Analysts' opinions of the day: Kering splits, news on Abivax, Soitec and Novo Nordisk Zonebourse
09/07/25 Imerys: Oddo BHF cuts target price Zonebourse
29/04/25 Imerys: Q1 '25: Decline and Uncertainty Alphavalue
22/02/25 Imerys: Margin growth despite uneven market conditions Alphavalue
21/01/25 Imerys: EPS cut (2024: -1.3%, 2025: -19.6%) Alphavalue
28/11/24 Imerys: Berenberg cuts target, maintains buy rating Zonebourse
31/10/24 Imerys: Sequential volume growth offers reassurance Alphavalue
03/10/24 Imerys: EPS cut (2024: -29.0%, 2025: -6.0%) Alphavalue
19/09/24 Imerys: up sharply after positive analysis Zonebourse
18/09/24 Imerys: a stock to own in 2025, according to Berenberg Zonebourse
12/09/24 Imerys: Target cut by -23.8% Alphavalue
01/08/24 Imerys: Gradual progress in operations amid a cautious outlook Alphavalue

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+6.43%
-18.07%
-5.49%
+29.97%
- - -
+25.14%
+27.46%
+28.73%
+33.09%
+9.82%
Average +15.23%
Weighted average by Cap. +1.29%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
23.78EUR
Average target price
25.65EUR
Spread / Average Target
+7.86%
High Price Target
30.00EUR
Spread / Highest target
+26.16%
Low Price Target
23.00EUR
Spread / Lowest Target
-3.28%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
AA
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!